Ani Pharmaceuticals Inc. (BSFA)
XSTU
Real-time Data
06:00 AM
Day's Range
63.0052 wk Range
61.00Overview - BSFA - Ani Pharmaceuticals Inc.
Key Statistics
Valuation
Enterprise Value
1.38B
P/E (Trailing)
‪16.28‬
PEG Ratio
‪0.08‬
Price / Sales (TTM)
‪1.50‬
Price / Book
‪2.68‬
EV / EBITDA
‪7.73‬
Profitability
Gross Margin
‪62.35%‬
Profit Margin
‪11.07%‬
Operating Margin
‪14.97%‬
Return on Assets
‪5.44%‬
Return on Equity
‪20.45%‬
Ownership
Shares Outstanding
22.97M
Float
19.64M
Held by Insiders
‪5.45%‬
Held by Institutions
‪107.21%‬
Price stats
Beta
‪0.46‬
50-Day Avg
‪69.87‬
200-Day Avg
‪68.15‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - BSFA - Ani Pharmaceuticals Inc.
Peers - BSFA - Ani Pharmaceuticals Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on XSTU.
- BSFAXSTUAni Pharmaceuticals Inc.1.51BMarket Cap-20.31%52-week change16.79P/E (Trailing)‪11.07%‬Profit Margin
- H6DXSTUHaleon Plc - ADR72.13BMarket Cap+2.35%52-week change23.61P/E (Trailing)‪64.18%‬Profit Margin
- MRKCXSTUMerck KGaA – Sponsored ADR59.12BMarket Cap+21.17%52-week change23.05P/E (Trailing)‪11.21%‬Profit Margin
- D8Y0XSTUSandoz Group AG ADR33.96BMarket Cap+32.05%52-week change62.80P/E (Trailing)‪5.53%‬Profit Margin
- 08HHXSTUShanghai Fosun Pharmaceutical Group Co., Ltd.4.84BMarket Cap-24.89%52-week change11.06P/E (Trailing)‪8.21%‬Profit Margin
- 41LXSTULaboratorios Farmacéuticos Rovi SA4.08BMarket Cap+3.09%52-week change121.98P/E (Trailing)‪64.92%‬Profit Margin
- HM6AXSTUHypera S.A. Sponsored ADR2.39BMarket Cap+12.28%52-week change7.73P/E (Trailing)‪19.82%‬Profit Margin
Profile Summary - BSFA - Ani Pharmaceuticals Inc.
About
ANI Pharmaceuticals Inc. is a diversified biopharmaceutical company that develops, manufactures, and markets branded and generic prescription pharmaceuticals. It specializes in a range of dosage forms, including liquid, powder, oral solid-dose products, injectables, softgel capsules, semi-solids, topicals, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
